30.03.2017 • News

Dow Completes Freeport Cracker

(c) DOW
(c) DOW

Dow Chemical has completed the construction of its 1.5 million t/y ethylene plant at Freeport, Texas, USA, with commissioning now underway and start-up expected by the middle of this year. The addition of the cracker takes Dow’s olefins capacity at Freeport to above 4 million t/y.

The facility will feed several derivative units that will come on stream throughout 2017 and 2018. These include plants producing 400,000 t/y Elite PE; 350,000 t/y specialty LDPE grades; 200,000 t/y next-generation Nordel metallocene ethylene propylene diene monomer (EPDM); and 320,000 t/y of specialty and conventional polyolefin elastomers with a high melt index. A debottlenecking of bimodal gas-phase PE capacity will also add 125,000 t/y.

 “The Freeport ethylene unit is the cornerstone of our $6 billion investment in the US Gulf Coast. Our growth investments leverage the advantaged shale gas supply available in the US and represent thousands of new jobs and significant economic value, including exports of approximately 20% of our US production,” said Andrew Liveris, Dow Chemical’s chairman and CEO.

Jim Fitterling, Dow Chemical’s president and chief operating officer, added that the unit provides the critical building blocks to bolster its competitive advantage in targeted consumer-led markets, including packaging, transportation, infrastructure and consumer care. “Not only does this investment leverage Dow’s early-mover advantage in shale gas, but it will also fuel the industry’s broadest and most differentiated derivatives slate, featuring Dow’s proprietary catalyst and process technologies to meet growing consumer demand throughout the Americas,” he said.

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read